Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

被引:2326
作者
Goossens, H [1 ]
Ferech, M
Stichele, RV
Elseviers, M
机构
[1] Univ Antwerp, Dept Microbiol, ESAC Management Team, B-2610 Antwerp, Belgium
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1016/S0140-6736(05)17907-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Resistance to antibiotics is a major public-health problem and antibiotic use is being increasingly recognised as the main selective pressure driving this resistance. Our aim was to assess outpatient use of antibiotics and the association with resistance. Methods We, investigated outpatient antibiotic use in 26 countries in Europe that provided. internationally M comparable distribution or reimbursement data, between Jan 1, 1997, and Dec 31, 2002; by calculating the number R of defined daily doses (DDD) per 1000 inhabitants per day, according to WHO anatomic therapeutic chemical M classification and DDD measurement methodology. We assessed the ecological association between antibiotic use and antibiotic resistance rates using Spearman's correlation coefficients. Findings Prescription of antibiotics in primary care in Europe varied greatly; the highest rate was in France (32.2 DDD per 1000 inhabitants daily) and the lowest was in the Netherlands (10.0 DDD per 1000 inhabitants daily). We noted a shift from the old narrow-spectrum antibiotics to the new broad-spectrum antibiotics. We also recorded striking seasonal fluctuations with heightened winter peaks in countries with high yearly use of antibiotics. We showed higher rates of antibiotic resistance in high consuming countries, probably related, to the higher consumption in southern and eastern Europe than in northern Europe. Interpretation These data might provide a useful method for assessing public-health strategies that aim to reduce antibiotic use and resistance levels.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 31 条
[1]   Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes [J].
Albrich, WC ;
Monnet, DL ;
Harbarth, S .
EMERGING INFECTIOUS DISEASES, 2004, 10 (03) :514-517
[2]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156
[3]   Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001 [J].
Bergman, M ;
Huikko, S ;
Pihlajamäki, M ;
Laippala, P ;
Palva, E ;
Huovinen, P ;
Seppälä, H .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1251-1256
[4]  
BRONZWAER S, 2003, THESIS RIJKSUNIVERSI
[5]  
Bronzwaer SL, 2000, EMERG INFECT DIS, V3, P278
[6]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[7]   Harbinger of fluoroquinolone resistance [J].
Chow, KM ;
Szeto, CC .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1617-1617
[8]  
*DAN VET LAB, 2001, DANMAP 2000 CONS ANT
[9]  
DELAAT E, 2002, DOES PHARM MARKETING
[10]  
DESCHEPPER R, 2002, PATIENT EDUC COUNS, V1590, P1